Postdoc in immunotherapy for cross-allergic diseases based on mRNA-LNPs - DTU Bioengineering

DTU · Kgs. Lyngby, Denmark

Don’t apply blind. See how your CV matches Engineer first — free, in 30 seconds.

You will continue to the employer’s original posting.

Company
DTU
Location
Kgs. Lyngby, Denmark
Posted
August 12, 2026

About this job

Allergic diseases affect 30 to 40% of the global population, and many patients are polysensitised, reacting to multiple structurally related allergens due to cross-reactivity. Current allergen immunotherapy requires 3 to 5 years of repeated exposure, often causes adverse reactions, and typically targets only one allergen at a time. We are working on a translational project combining allergen design with mRNA lipid nanoparticle (LNP)-based delivery to generate broadly protective immune responses against cross-reactive allergen families, starting with nsLTP-mediated food and pollen allergy. We seek a highly motivated Postdoctoral Researcher with strong immunology and molecular biology expertise to lead formulation optimisation and indication expansion for our mRNA-LNP allergen immunotherapy

This is a short summary. Want to know if you're a fit? Check your CV against this role — free, in 30 seconds.

Similar jobs

See if your CV fits this job

Paste your CV for an instant match score against this role — and get a tailored cover letter in one click.

  • Instant match score for this role
  • Tailored cover letter in one click
  • Free — no credit card
Check my CV — free